UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
High-speed microscope captured fleeting brain signals
On Mar. 19, 2020, University of California, Berkeley, investigators have now built such a camera: a microscope that…
Cumberland Pharmaceuticals announced initiative to expand availability of Caldolor to treat fevers associated with Coronavirus Infections
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561,000 contract from the U.S. Department…
Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virus
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
LabCorp sets dedicated hours to serve the non-COVID-19 testing needs for elderly and most vulnerable people
On Mar. 19, 2020, LabCorp announced it is dedicating the first hour of service each day at its…
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
Edmonton company Entos Pharma developing DNA vaccine against COVID-19
On Mar. 18, 2020, Entos Pharmaceuticals announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections….
Researcher proved one of Darwin’s theories of evolution 140 years after his death
On Mar. 18, 2020, Laura van Holstein and and Robert A. Foley published “Terrestrial habitats decouple the relationship…
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
Biotechnology | COVID-19 | FDA | Therapeutics
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
Eli Lilly and Indiana State Department of Health partnered to accelerate COVID-19 testing using Lilly Research Laboratories
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
Emergent Biosolutions signed development and manufacturing agreement with Vaxart for experimental Coronavirus oral vaccine
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
Nike leaders donated $7 million to support OHSU’s COVID-19 response
On Mar. 18, 2020, Nike CEO John Donahoe and his wife, Eileen, along with Nike Chairman Mark Parker…
Getinge increased production capacity of ventilators with 60% to support the needs of global ICU’s
On Mar. 17, 2020, Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand…
Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
Israel weighed “compassionate use” of Pluristem therapy for COVID-19
On Mar. 17, 2020, Israel’s Health Ministry announced that it had approved a request by Pluristem Therapeutics to…
Biotechnology | COVID-19 | Diagnostics | FDA
Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assay
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
MannKind refocuses pipeline resources in response to COVID-19 pandemic
On Mar. 17, 2020, MannKind announced it is adjusting research and development resources that were reserved for its…
Genomic analysis showed COVID-19 coronavirus epidemic has a natural origin
On Mar. 17, 2020, scientists reported the novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China,…
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
Latest FDA guidance allows distribution of SARS-CoV-2 serology tests for diagnostic use
On Mar. 17, 2020, BioMedomics announced it will be able to distribute their COVID-19 IgM-IgG Antibody Rapid Test…
BioReference Laboratories and NYC Health + Hospitals announced collaboration to provide Coronavirus testing
On Mar. 17, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the New York City…
Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…